Literature DB >> 7816818

Overexpression of plasminogen activator inhibitor 2 in human melanoma cells inhibits spontaneous metastasis in scid/scid mice.

B M Mueller1, Y B Yu, W E Laug.   

Abstract

A metastatic human melanoma cell line that produces urokinase-type plasminogen activator was stably transfected with cDNA encoding human plasminogen activator inhibitor 2 (PAI-2). Transfected clones expressed PAI-2 at levels two to nine times higher than both the parental cell line and mock transfectants, as detected by ELISA of cell lysates and conditioned medium. The clone with the highest PAI-2 expression exhibited complete inhibition of soluble and cell-surface-bound plasminogen activator activity. The level of PAI-2 overexpression in these clonal cell lines correlated positively with the inhibition of their ability to degrade extracellular matrix in vitro. Parental, mock-transfected, and PAI-2-transfected cell lines produced rapidly growing tumors when injected s.c. into the skin of mice with severe combined immunodeficiency. The tumors producing the highest levels of PAI-2 were surrounded by a dense tumor capsule. Both parental cells and mock-transfected cells invariably metastasized from s.c. tumors to lymph nodes and lungs of mice. PAI-2-transfected cell lines produced significantly less or no metastases. Taken together, these data indicate a critical role for plasminogen activator activity in melanoma invasion and metastasis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7816818      PMCID: PMC42846          DOI: 10.1073/pnas.92.1.205

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Internalization of the urokinase-plasminogen activator inhibitor type-1 complex is mediated by the urokinase receptor.

Authors:  D Olson; J Pöllänen; G Høyer-Hansen; E Rønne; K Sakaguchi; T C Wun; E Appella; K Danø; F Blasi
Journal:  J Biol Chem       Date:  1992-05-05       Impact factor: 5.157

Review 2.  Urokinase-dependent proteolysis in cultured colon cancer is directed by its receptor.

Authors:  W Hollas; D Boyd
Journal:  Semin Thromb Hemost       Date:  1991-07       Impact factor: 4.180

Review 3.  The plasminogen activator/plasmin system.

Authors:  J D Vassalli; A P Sappino; D Belin
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

4.  Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases.

Authors:  Y A DeClerck; N Perez; H Shimada; T C Boone; K E Langley; S M Taylor
Journal:  Cancer Res       Date:  1992-02-01       Impact factor: 12.701

Review 5.  The role of proteolytic enzymes in cancer invasion and metastasis.

Authors:  M J Duffy
Journal:  Clin Exp Metastasis       Date:  1992-05       Impact factor: 5.150

6.  Suppression of spontaneous melanoma metastasis in scid mice with an antibody to the epidermal growth factor receptor.

Authors:  B M Mueller; C A Romerdahl; J M Trent; R A Reisfeld
Journal:  Cancer Res       Date:  1991-04-15       Impact factor: 12.701

7.  Plasminogen-activator inhibitor type 1 is a potent natural inhibitor of extracellular matrix degradation by fibrosarcoma and colon carcinoma cells.

Authors:  J F Cajot; J Bamat; G E Bergonzelli; E K Kruithof; R L Medcalf; J Testuz; B Sordat
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

8.  Relationship between secreted urokinase plasminogen activator activity and metastatic potential in murine B16 cells transfected with human urokinase sense and antisense genes.

Authors:  H R Yu; R M Schultz
Journal:  Cancer Res       Date:  1990-12-01       Impact factor: 12.701

9.  Clonal variation of expression of the genes coding for plasminogen activators, their inhibitors and the urokinase receptor in HT1080 sarcoma cells.

Authors:  W E Laug; K Wang; R Mundi; W Rideout; E K Kruithof; E Bogenmann
Journal:  Int J Cancer       Date:  1992-09-09       Impact factor: 7.396

10.  Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation.

Authors:  P H Quax; G N van Muijen; E J Weening-Verhoeff; L R Lund; K Danø; D J Ruiter; J H Verheijen
Journal:  J Cell Biol       Date:  1991-10       Impact factor: 10.539

View more
  22 in total

1.  Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin.

Authors:  D A Waltz; L R Natkin; R M Fujita; Y Wei; H A Chapman
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

2.  The plasminogen activator inhibitor-2 gene is not required for normal murine development or survival.

Authors:  K M Dougherty; J M Pearson; A Y Yang; R J Westrick; M S Baker; D Ginsburg
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

3.  Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells.

Authors:  S Sheng; J Carey; E A Seftor; L Dias; M J Hendrix; R Sager
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

4.  Suppression of breast cancer growth and metastasis by a serpin myoepithelium-derived serine proteinase inhibitor expressed in the mammary myoepithelial cells.

Authors:  G Xiao; Y E Liu; R Gentz; Q A Sang; J Ni; I D Goldberg; Y E Shi
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

5.  A new long noncoding RNA (lncRNA) is induced in cutaneous squamous cell carcinoma and down-regulates several anticancer and cell differentiation genes in mouse.

Authors:  Gilles Ponzio; Roger Rezzonico; Isabelle Bourget; Richard Allan; Nicolas Nottet; Alexandra Popa; Virginie Magnone; Géraldine Rios; Bernard Mari; Pascal Barbry
Journal:  J Biol Chem       Date:  2017-06-08       Impact factor: 5.157

6.  Characterisation of PAUSE-1, a powerful silencer in the human plasminogen activator inhibitor type 2 gene promoter.

Authors:  S M Ogbourne; T M Antalis
Journal:  Nucleic Acids Res       Date:  2001-10-01       Impact factor: 16.971

7.  A systems biology analysis of metastatic melanoma using in-depth three-dimensional protein profiling.

Authors:  Mee-Jung Han; Huan Wang; Lynn A Beer; Hsin-Yao Tang; Meenhard Herlyn; David W Speicher
Journal:  Proteomics       Date:  2010-11-17       Impact factor: 3.984

8.  Immunohistochemical expressions of uPA and its receptor uPAR and their prognostic significant in urinary bladder carcinoma.

Authors:  Attalla Farag El-Kott; Abdalla Mohamed Khalil; Ayman El-Meghawry El-Kenawy
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

Review 9.  Expression genetics in cancer: shifting the focus from DNA to RNA.

Authors:  R Sager
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-04       Impact factor: 11.205

10.  Pre-clinical study of 213Bi labeled PAI2 for the control of micrometastatic pancreatic cancer.

Authors:  Chang F Qu; Emma Y Song; Yong Li; Syed M A Rizvi; Chand Raja; Ross Smith; Alfred Morgenstern; C Apostolidis; Barry J Allen
Journal:  Clin Exp Metastasis       Date:  2006-02-11       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.